Skip to content
Wenlo
Sign in
← Markets

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. (IOVA) — Form 4: Insider transaction

4IOVAFiled Nov 10, 2026, 12:00 PM ET· Period Nov 6, 2026

About this filing

Iovance Biotherapeutics, Inc. (IOVA) filed Form 4 (insider transaction) with the SEC on Nov 10, 2026. Form 4 reports a company insider’s trades in the company’s shares.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.

More IOVA filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.